An intra-group merger by absorption in January 2025, with 株式会社グルプス as the surviving company and 株式会社オルリンクス製薬 as the absorbed company. Following the merger, the surviving company changed its corporate name to オルクス株式会社. This organizational restructuring is intended to improve the efficiency of management resources and strengthen the management base.